Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05322538 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Menier's Disease - Bone Density Study

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Jul 1, 2022 to Oct 1, 2022v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Meniere's disease is a progressive and debilitating inner ear disease characterised by vertigo and hearing loss. Several studies have linked Menierws disease with lower bone density and lower vitamin D levels. In the current prospective study definite Meniere's patients will be followed over a period of 2 year, during which repetitive measurements of bone density, vitamin D plasma levels, blood pressure as well as hearing and vestibular tests will be made. Results will be compared to healthy controls.
Trial Details
NCT Number NCT05322538
Lead Sponsor HaEmek Medical Center, Israel
Conditions
(from sponsor)		 Meniere Disease, Osteoporosis, Osteopenia, Vitamin D Deficiency, Vestibular Disorder
Related terms Bone Diseases, Metabolic, Meniere Disease, Osteoporosis, Vestibular Diseases, Vitamin D Deficiency
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov